GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)

$1,244,501
Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2023 · CA

Molecular Analysis of Breast Cancer Metastasis to the Brain

$1,243,905
Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Architecture and Trajectory of Acquired Resistance to Therapy in AML

$1,243,548
Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2024 · CA

Modulation of Therapeutic Response

$1,242,928
James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA

Novel Strategies for Brain Tumor Therapy

$1,240,698
Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · NS

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,240,024
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,240,024
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Center for Advanced Multi-Omic Characterization of Cancer

$1,240,013
Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2022 · CA

Center for Advanced Multi-Omic Characterization of Cancer

$1,240,013
Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2025 · CA

Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy

$1,239,509
Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2025 · CA

Multiplexed imaging of chromatin folding and RNA profiles in cancer

$1,237,899
Siyuan Wang · Yale University · R33 · FY2020 · CA

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,237,451
Upender Manne · University Of Alabama At Birmingham · U54 · FY2021 · CA

Novel Strategies for Brain Tumor Therapy

$1,237,378
Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · NS

Novel Strategies for Brain Tumor Therapy

$1,237,376
Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · NS

Novel Strategies for Brain Tumor Therapy

$1,237,376
Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · NS

A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies

$1,237,360
Ryan Gessner · Sonovol, Inc. · R44 · FY2021 · CA

The Houston Center for Acquired Resistance Research (H-CARR)

$1,237,322
Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA

Novel SCD1 inhibitors for treatment of cancer

$1,236,819
John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA

Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC

$1,236,441
Andrew N Lane · University Of Kentucky · P01 · FY2014 · CA

NF Center: from animal models to therapeutics

$1,235,539
Luis F Parada · Ut Southwestern Medical Center · P50 · FY2011 · NS

Mutographs differentiating the racial and temporal incidence of multiple myeloma

$1,234,790
Gareth John Morgan · New York University School Of Medicine · R01 · FY2021 · CA

Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma

$1,234,699
Fabien Maldonado · Vanderbilt University Medical Center · U01 · FY2019 · CA

COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS

$1,234,505
The General Hospital Corporation · · FY2025 · Defense Health Agency

Development of an extracellular matrix-targeted theranostic radiopharmaceutical for metastatic lung cancer

$1,233,778
Dennis Zimmermann · Matrisome Bio, Inc. · R44 · FY2025 · CA

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,232,770
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA